Compare MSS & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSS | NOTV |
|---|---|---|
| Founded | 2019 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 12.7M |
| IPO Year | 2023 | 1997 |
| Metric | MSS | NOTV |
|---|---|---|
| Price | $0.21 | $0.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.50 | $1.50 |
| AVG Volume (30 Days) | ★ 2.9M | 549.0K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 136.84 | 49.64 |
| EPS | ★ N/A | N/A |
| Revenue | $124,217,480.00 | ★ $547,656,000.00 |
| Revenue This Year | N/A | $5.28 |
| Revenue Next Year | $7.09 | $5.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 114.01 | ★ 511.19 |
| 52 Week Low | $0.21 | $0.25 |
| 52 Week High | $3.96 | $3.35 |
| Indicator | MSS | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 45.21 |
| Support Level | N/A | $0.26 |
| Resistance Level | $0.31 | $0.65 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 3.32 | 37.97 |
Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.